Twist Bioscience Q3 EPS Falls Short by $0.08, Revenue Tops Estimates
Twist Bioscience reports Q3 revenue of $118.4M, beating estimates, but GAAP EPS misses by $0.08. Twist Bioscience posted a Q3 GAAP loss per share of $0.56, missing estimates by $0.08. Revenue reached $118.4 million, up 23.2% year-over-year and exceeding expectations by $3.